๐ฐ Merck Sharp News
Page 85 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
January 18, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the companys novel,...
January 18, 2022
DUBLIN, Jan. 18, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the company's novel, investigational, engineered
January 18, 2022
This randomized clinical trial evaluates the benefits and risks of the addition of a P2Y12 inhibitor to anticoagulant therapy compared with anticoagulant therap
January 17, 2022
TOKYO, Jan 17, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: LENVIMA
January 17, 2022
/PRNewswire/ -- Allied Market Research recently published a report, titled, "Liver Disease Treatment Market by Treatment Type (Antiviral Drugs,...
January 15, 2022
At the end of last month, three amicus curiae briefs were filed following the petition for a writ of certiorari in the Amgen, Inc. v. Sanofi, Inc. case. We previously discussed the...
January 15, 2022
Creators of molnupiravir say data suggests pill could be โmulti-virus weaponโ and suppress transmission
January 15, 2022
Taipei, Jan. 15 (CNA) Taiwan has signed a deal with Pfizer to procure 20,000 courses of the oral COVID-19 treatment Paxlovid, with the first batch expected to arrive before March, Minister of Health and Welfare Chen Shih-chung (้ณๆไธญ) said Saturday.
January 14, 2022
/PRNewswire/ -- Eisai announced today the presentation of six abstracts across various gastrointestinal cancers during the 2022 American Society of Clinical...
January 13, 2022
Massachusetts federal and state courts issued several important product liability decisions in 2021. Nutterโs Product Liability practice group reviewed these cases and report on their...